Insider · CIK 0001999774
Russell Kevin Klass
Files at ZOMDF (Zomedica Corp.). First filing Jun 12, 2024, latest May 26, 2026.
In brief
Russell Kevin Klass files SEC Form 4 as officer at ZOMDF (Zomedica Corp.). Since Jun 12, 2024, Russell Kevin Klass has reported 13 open-market buys worth $423k and 0 open-market sells worth $0, the latest filed on May 26, 2026.
After Russell Kevin Klass's past buys, the stock beat the S&P 500 by a median 7.3% over six months (n = 8), and 75% of those buys were ahead of the index at six months. InsiderTell labels that a positive record.
The newest scored trade: bought $11k of ZOMDF on May 21, 2026, filed May 26, 2026, scored 56 (moderate). In the last 12 months: 6 buys worth $81k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZOMDF: Zomedica Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | Zomedica Corp. | $11k 104,000 shares | - | +184% from low-32% from high | |
| 36Weak | Zomedica Corp. | $23k 216,899 shares | +4% | +189% from low-31% from high | |
| 28Weak | ZOMDFbuy Zomedica Corp. | $15k 150,000 shares | +3% | +213% from low-36% from high | |
| 28Weak | ZOMDFbuy Zomedica Corp. | $12k 120,000 shares | +2% | +223% from low-34% from high | |
| 23Weak | ZOMDFbuy Zomedica Corp. | $475 5,000 shares | +0% | +220% from low-35% from high | |
| 28Weak | ZOMDFbuy Zomedica Corp. | $20k 253,007 shares | +5% | +180% from low-43% from high | |
| 40Moderate | ZOMDFbuy Zomedica Corp. | $42k 1,056,064 shares | +25% | +30% from low-74% from high | |
| 26Weak | ZOMDFbuy Zomedica Corp. | $20k 500,000 shares | +16% | +23% from low-75% from high | |
| 31Weak | ZOMDFbuy Zomedica Corp. | $20k 500,000 shares | +14% | +30% from low-74% from high | |
| 43Moderate | Zomedica Corp. | $49k 699,980 shares | +28% | - | |
| 43Moderate | Zomedica Corp. | $60k 500,000 shares | +50% | - | |
| 50Moderate | Zomedica Corp. | $47k 299,993 shares | +18% | +27% from low-34% from high | |
| 56Moderate | Zomedica Corp. | $105k 700,007 shares | +70% | +25% from low-35% from high |
Transactions
Every row this insider has filed, 25 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | ZOMDF Zomedica Corp. | AGrant or award Options to buy Common Stockderivative | +250,000 | $0.00 | $0 | 250,000 | Aug 7, 2026 |
| May 21, 2026 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par valueindirect: spouse | +104,000 | $0.10 | $11k | 104,000 | May 26, 2026 |
| May 20, 2026 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +200,000 | $0.11 | $21k | 5,984,101 | May 21, 2026 |
| May 21, 2026 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +11,399 | $0.11 | $1,220 | 5,995,500 | May 21, 2026 |
| May 21, 2026 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +5,500 | $0.11 | $578 | 6,001,000 | May 21, 2026 |
| Nov 13, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +150,000 | $0.10 | $15k | 5,784,101 | Nov 14, 2025 |
| Nov 10, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value. | +120,000 | $0.10 | $12k | 5,634,101 | Nov 12, 2025 |
| Nov 7, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +5,000 | $0.10 | $475 | 5,514,101 | Nov 10, 2025 |
| Nov 6, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +253,007 | $0.08 | $20k | 5,509,101 | Nov 7, 2025 |
| Aug 11, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +60,723 | $0.04 | $2,429 | 4,260,753 | Aug 13, 2025 |
| Aug 12, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $10k | 4,510,753 | Aug 13, 2025 |
| Aug 12, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +745,341 | $0.04 | $30k | 5,256,094 | Aug 13, 2025 |
| Aug 11, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $9,500 | 3,950,030 | Aug 12, 2025 |
| Aug 8, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +500,000 | $0.04 | $20k | 3,700,030 | Aug 12, 2025 |
| Aug 11, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $10k | 4,200,030 | Aug 12, 2025 |
| Jun 12, 2025 | ZOMDF Zomedica Corp. | AGrant or award Options to buy Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Jun 16, 2025 |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without $0.070 par value | +699,980 | $0.07 | $49k | 3,200,030 | Mar 18, 2025 |
| Feb 21, 2025 | ZOMDF Zomedica Corp. | AGrant or award Option to buy common stockderivative | +200,000 | $0.00 | $0 | 200,000 | Feb 24, 2025 |
| Nov 11, 2024 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +210,200 | $0.12 | $25k | 1,210,250 | Nov 12, 2024 |
| Nov 11, 2024 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +289,800 | $0.12 | $35k | 1,500,050 | Nov 12, 2024 |
| Jun 12, 2024 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +299,993 | $0.16 | $47k | 2,000,050 | Jun 13, 2024 |
| Jun 10, 2024 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +200,007 | $0.15 | $30k | 1,200,057 | Jun 12, 2024 |
| Jun 11, 2024 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +500,000 | $0.15 | $75k | 1,700,057 | Jun 12, 2024 |
| Nov 7, 2023 | ZOMDF Zomedica Corp. | AGrant or award Option to Buy Common Stockderivative | +2,000,000 | $0.00 | $0 | 2,000,000 | Nov 14, 2023 |
| Nov 7, 2023 | ZOMDF Zomedica Corp. | AGrant or award Option to Buy Common Stockderivative | +2,000,000 | $0.00 | $0 | 2,000,000 | Nov 9, 2023 |
Questions about Russell Kevin Klass
Answered from the filings on this page, as of the latest one.
Is Russell Kevin Klass buying or selling?
In the last 12 months Russell Kevin Klass reported 6 open-market buys worth $81k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $11k of ZOMDF on May 21, 2026. Grants, option exercises and tax withholding are not counted.
How did Russell Kevin Klass's past buys perform?
Measured from the first close after each filing, the stock beat the S&P 500 by a median 7.3% over six months across 8 past buys, with 75% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Russell Kevin Klass file Form 4?
Russell Kevin Klass has filed Form 4 at ZOMDF (Zomedica Corp.) as Vice President of Sales. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.